Search results for "multidrug resistant"

showing 8 items of 8 documents

Repurposing old drugs to fight multidrug resistant cancers.

2020

Overcoming multidrug resistance represents a major challenge for cancer treatment. In the search for new chemotherapeutics to treat malignant diseases, drug repurposing gained a tremendous interest during the past years. Repositioning candidates have often emerged through several stages of clinical drug development, and may even be marketed, thus attracting the attention and interest of pharmaceutical companies as well as regulatory agencies. Typically, drug repositioning has been serendipitous, using undesired side effects of small molecule drugs to exploit new disease indications. As bioinformatics gain increasing popularity as an integral component of drug discovery, more rational approa…

0301 basic medicineVirtual screeningCancer ResearchDrug repurposingSettore BIO/11 - Biologia MolecolareAntineoplastic AgentsDrug resistanceBioinformatics03 medical and health sciencesClinical cancer trials; Drug repurposing; Multidrug resistant cancer; Pharmacophore modelling; Virtual screening0302 clinical medicineNeoplasmsDrug DiscoveryMedicineHumansPharmacology (medical)Computer SimulationRepurposingPharmacologyVirtual screeningDrug discoverybusiness.industryDrug RepositioningComputational BiologyDrug Resistance Multiple3. Good healthMultiple drug resistanceDrug repositioning030104 developmental biologyInfectious DiseasesOncologyDrug developmentDrug Resistance Neoplasm030220 oncology & carcinogenesisMultidrug resistant cancerPharmacophore modellingPharmacophorebusinessClinical cancer trialsDrug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
researchProduct

No-touch methods of terminal cleaning in the intensive care unit: results from the first large randomized trial with patient-centred outcomes

2017

N/A

Cross infectionmedicine.medical_specialtySepsiICU-acquired infections; Multidrug resistant organisms; Sepsis; Terminal cleaningIntensive Care UnitMEDLINEMultidrug resistant organismCritical Care and Intensive Care MedicineArticlelaw.inventionSepsis03 medical and health sciencesICU-acquired infection0302 clinical medicineRandomized controlled triallawSepsismedicineHumans030212 general & internal medicineTerminal cleaningIntensive care medicineCross Infectionbusiness.industryMultidrug resistant organismslcsh:Medical emergencies. Critical care. Intensive care. First aid030208 emergency & critical care medicinelcsh:RC86-88.9medicine.diseaseIntensive care unitTerminal cleaningIntensive Care UnitsEmergency medicineICU-acquired infections; Multidrug resistant organisms; Sepsis; Terminal cleaning; Humans; Cross Infection; Intensive Care Units; Critical Care and Intensive Care MedicinebusinessICU-acquired infectionsPatient centredHumanCritical Care
researchProduct

Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of …

2017

Summary Background Patients admitted to hospital can acquire multidrug-resistant organisms and Clostridium difficile from inadequately disinfected environmental surfaces. We determined the effect of three enhanced strategies for terminal room disinfection (disinfection of a room between occupying patients) on acquisition and infection due to meticillin-resistant Staphylococcus aureus , vancomycin-resistant enterococci, C difficile , and multidrug-resistant Acinetobacter . Methods We did a pragmatic, cluster-randomised, crossover trial at nine hospitals in the southeastern USA. Rooms from which a patient with infection or colonisation with a target organism was discharged were terminally dis…

Malemedicine.medical_specialtyLetterSodium HypochloriteUltraviolet RaysDisinfectantPopulationDrug resistance030501 epidemiologyMicrobiology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineDrug Resistance Multiple BacterialSepsisPatients' RoomsMedicineHumans030212 general & internal medicineeducationeducation.field_of_studyCross InfectionCross-Over Studiesbusiness.industryClostridioides difficileMultidrug resistant organismsIncidence (epidemiology)General MedicineClostridium difficileMiddle AgedCrossover studyUnited StatesTerminal cleaningDisinfectionQuaternary Ammonium CompoundschemistrySodium hypochloriteRelative riskClostridium InfectionsFemale0305 other medical sciencebusinessICU-acquired infectionsDisinfectantsLancet (London, England)
researchProduct

Healthcare-Associated Pneumonia and Multidrug Resistant Bacteria: Do We Have a Convincing Answer?

2014

Methicillin-Resistant Staphylococcus aureusMicrobiology (medical)medicine.medical_specialtyBacteriabusiness.industryMedicine (all)Drug ResistanceBacterialPneumonia Ventilator-AssociatedBacteria; Enterobacteriaceae; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia Ventilator-Associated; Pseudomonas aeruginosa; Drug Resistance Bacterial; Infectious Diseases; Microbiology (medical); Medicine (all)Pneumoniamedicine.diseasePneumoniaVentilator-AssociatedMultidrug resistant bacteriaInfectious DiseasesHealthcare associatedEnterobacteriaceaeDrug Resistance BacterialPseudomonas aeruginosamedicineBacteria; Enterobacteriaceae; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia; Ventilator-Associated; Pseudomonas aeruginosa; Drug Resistance; Bacterial; Infectious Diseases; Microbiology (medical); Medicine (all)HumansIntensive care medicinebusiness
researchProduct

Prevention of nosocomial infections and surveillance of emerging resistances in NICU

2011

Neonates hospitalized in NICU are at risk for healthcare associated infections because of their poor immune defenses, related to gestational age, colonization of mucous membranes and skin with nosocomial microorganisms, exposure to antibiotics, invasive procedures and frequent contacts with healthcare workers (HCWs). Healthcare associated infections are the major source of morbidity and mortality in NICU in the developed world. Most infections are caused by Gram-positive organisms, fulminant sepsis are often associated to Gram-negative organisms, fungal sepsis occurs frequently in ELBW infants. Hand hygiene is the most important preventive procedure, nevertheless hand hygiene compliance amo…

Methicillin-Resistant Staphylococcus aureusmedicine.medical_specialtymedicine.drug_classprevention surveillance nosocomial infections resistance neonate multidrug resistant organisms methicillin resistant staphylococcus aureusmedia_common.quotation_subjectAntibioticsDrug resistancemedicine.disease_causeCommunicable Diseases EmergingSepsisSettore MED/38 - Pediatria Generale E SpecialisticaHygieneIntensive Care Units NeonatalHumansMedicineIntensive care medicinemedia_commonCross InfectionInfection Controlbusiness.industryTransmission (medicine)Infant NewbornObstetrics and GynecologyDrug Resistance Microbialmedicine.diseaseAntimicrobialMethicillin-resistant Staphylococcus aureusDrug Resistance MultiplePopulation SurveillancePediatrics Perinatology and Child HealthbusinessFluconazolemedicine.drugThe Journal of Maternal-Fetal & Neonatal Medicine
researchProduct

In vitro activities of tetracyclines against different clones of multidrug-resistant Acinetobacter baumannii isolates from two Iranian hospitals.

2014

Acinetobacter baumannii has emerged as one of the most challenging healthcare-related pathogens and its occurrence has increased worldwide, especially in patients admitted to intensive care units. A. baumannii isolates are frequently resistant to multiple antimicrobial agents and there are recent reports of isolates resistant to virtually all clinically relevant drugs. In the present study, the in vitro activities of tigecycline, minocycline and doxycycline against 67 MDR-AB isolates recovered from 29 burn and 38 non-burn Iranian patients hospitalised in Tehran and Tabriz, respectively, were studied. Tigecycline and minocycline may be still considered effective therapeutic options for MDR-A…

Microbiology (medical)Acinetobacter baumanniiSettore MED/07 - Microbiologia E Microbiologia ClinicaGenotypeGeneral MedicineMicrobial Sensitivity TestsBiologyIranSettore MED/42 - Igiene Generale E ApplicataIn vitroHospitalsMicrobiologyAnti-Bacterial AgentsMolecular TypingInfectious DiseasesGenes BacterialTetracyclinesDrug Resistance Multiple BacterialHumansPharmacology (medical)Multidrug resistant Acinetobacter baumanniiAcinetobacter baumannii tetracyclines multiresistance IranAcinetobacter InfectionsInternational journal of antimicrobial agents
researchProduct

Surveillance of methicillin-resistant Staphylococcus aureus, multidrug-resistant Gram-negatives and fungi colonization in the Neonatal Intensive Care…

2015

Introduction Multidrug-resistant organisms are a serious public health problem, particularly in critical hospital wards such as the Neonatal Intensive Care Units (NICUs). Hospitalized neonates are at high risk for healthcare-associated infections leading to higher morbidity and mortality rates, because of their poor immune defences, frequent exposure to antibiotics, invasive procedures and contacts with healthcare-workers. Our study aimed to evaluate the prevalence of colonization by methicillin-resistant Staphylococcus aureus (MRSA), multidrug-resistant Gram-negatives (MDRGNs) and fungi in the five NICUs of the city of Palermo. Methods From February 2014 to January 2015, an active surveill…

Settore MED/38 - Pediatria Generale E Specialisticamultidrug resistant surveillance NICUSettore MED/42 - Igiene Generale E Applicata
researchProduct

Bloodstream infections in intensive care unit patients: Distribution and antibiotic resistance of bacteria

2015

Vincenzo Russotto,1 Andrea Cortegiani,1 Giorgio Graziano,2 Laura Saporito,2 Santi Maurizio Raineri,1 Caterina Mammina,2 Antonino Giarratano1 1Department of Biopathology and Medical Biotechnologies (DIBIMED), Section of Anaesthesia, Analgesia, Intensive Care and Emergency, Paolo Giaccone University Hospital, University of Palermo, Palermo, Italy; 2Department of Sciences for Health Promotion and Mother-Child Care, University of Palermo, Palermo, Italy Abstract: Bloodstream infections (BSIs) are among the leading infections in critically ill patients. The case-fatality rate associated with BSIs in patients admitted to intensive care units (ICUs) reaches 35%–50%. The emergence and diffusi…

medicine.medical_specialtybloodstream infectionsmedicine.drug_classAntibioticsICU; MDR; antibiotic; bloodstream infections; intensive care unit; multidrug resistantSettore MED/41 - AnestesiologiaReviewBloodstream infectionmedicine.disease_causelcsh:Infectious and parasitic diseaseslaw.inventionAntibiotic resistancelawIntensive careEpidemiologyMDRmedicinelcsh:RC109-216Pharmacology (medical)Intensive care unitMED/41 - ANESTESIOLOGIAIntensive care medicinePharmacologybiologybusiness.industryAntibioticAcinetobacterbiology.organism_classificationIntensive care unitMultiple drug resistanceInfectious DiseasesMultidrug resistantStaphylococcus aureusICUAntibiotic; Bloodstream infections; ICU; Intensive care unit; MDR; Multidrug resistantbusiness
researchProduct